These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 15160331)

  • 1. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
    J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
    Maruff P; Falleti MG; Collie A
    Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
    Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C
    Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
    Paraska K; Bender CM
    Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
    Weis J; Poppelreuter M; Bartsch HH
    Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
    Debess J; Riis JØ; Engebjerg MC; Ewertz M
    Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.